|
|
| The intervention with the strongest evidence |
| Low-dose vaginal estrogen |
| Moderate recommendation, evidence grade B |
|
| For postmenopausal women with recurrent UTIs, the 2025 AUA/CUA/SUFU guideline recommends it to reduce the risk of future infections. This is a clinician conversation, not a self-directed action, and it is not something to start without one. |
| |
| “In patients with GSM and recurrent urinary tract infections, clinicians should recommend local low-dose vaginal estrogen to reduce the risk for future urinary tract infections.” |
| AUA, SUFU and AUGS guideline, 2025 |
|
|
| What it is not |
| A treatment for a single infection in progress, or a substitute for a urine culture when you have symptoms. Current UTI symptoms need testing, because the guideline is clear that not every burning episode is a UTI and not every positive culture warrants antibiotics. |
|
|
| When to call |
| Burning with fever, chills, back or side pain, nausea, or vomiting is not a bladder issue anymore. That needs care the same day. |
| |
| Three or more UTIs in a year, or two in six months, is the threshold at which the guideline recommends further evaluation. |
| |
| Blood in urine that is not menstrual needs a call too. |
|
|
| This week |
|
|
Write down what you have seen. Approximate frequency, timing, any burning, any infections in the past year, whether it wakes you at night. |
|
|
Bring the list to a primary care visit, or ask for a referral to a urologist or urogynecologist. |
|
| The strongest treatment for this cluster needs a prescription and a conversation, and the conversation goes faster when you arrive with a record instead of trying to reconstruct one out loud. |
| One tap, no form |
| Which one is yours? |
| Tap the line that fits. It opens a reply with the subject already written, so you can send it as it is or add a sentence. Nothing is public, and what most of you tap decides which pattern gets explained next. |
|
|
|
|
|
|
|
|
| Or write in your own words. Every reply is read. |
|
|
|
|
|
| Every source read for this issue |
| Two multi-society clinical guidelines, one peer-reviewed review, one clinical reference, two professional society patient documents. |
| 1 |
The Menopause Society, MenoNote: Genitourinary Syndrome of Menopause Professional society patient education |
| |
| 2 |
AUA, SUFU and AUGS, Genitourinary Syndrome of Menopause Guideline Multi-society clinical guideline, 2025 |
| |
| 3 |
Angelou et al., review of genitourinary syndrome of menopause Peer-reviewed narrative review, 2022, prevalence range |
| |
| 4 |
StatPearls, Genitourinary Syndrome of Menopause Clinical reference, urgency and frequency figure |
| |
| 5 |
AUA, CUA and SUFU, Recurrent Uncomplicated UTI Guideline Clinical guideline, 2025, culture before treatment and systemic signs |
| |
| 6 |
Urology Care Foundation, Urinary Tract Infections in Adults Professional society patient education, three per year threshold |
|
|
|